Spravato Esketamine: What we know so far….

Spravato Esketamine: What we know so far….

The FDA approved a new esketamine nasal spray medication for treatment-resistant depression called Spravato, trade name for Esketamine on March 5, 2019. We’ve had many inquiries about the medication at our practice and I thought it would be beneficial to all of you to...

Sign-Up to Receive News & Special Offers

Be the first to hear about upcoming events and special offers, and stay up-to-date on the latest news in mental health and happiness.

You're in! Watch your inbox for emails from the Spring Center of Hope.

Pin It on Pinterest